CAMBRIDGE, Mass., June 11, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Wells Fargo Securities 2013 Healthcare Conference on Tuesday, June 18, 2013, at 1:10 p.m. ET at the InterContinental Hotel in Boston, MA. Management will also participate in a panel discussion on Hepatitis C earlier in the day at 10:00 a.m. ET. The live and archived webcast of the Company presentation can be accessed under "Events and Presentations" in the Idenix Investor Center at www.idenix.com . The archived replay will be available on the Idenix website for two weeks following the conference. ABOUT IDENIX PHARMACEUTICALS Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical Company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with hepatitis C virus (HCV) infection. For further information about Idenix, please refer to www.idenix.com .
CONTACT: Teri Dahlman (617) 995-9807